Thursday, October 17, 2019

Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: Happy 1 Year Anniversary Canada! (NYSE: $ACB) (TSXV: $GYSR.V) (CSE: $BOSS.C) (TSXV: $NRTH.V) (NASDAQ: $NEPT) (CSE: $SOL.C) (NEO: CCHW)

Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: Happy 1 Year Anniversary Canada! (NYSE: $ACB) (TSXV: $GYSR.V) (CSE: $BOSS.C) (TSXV: $NRTH.V) (NASDAQ: $NEPT) (CSE: $SOL.C) (NEO: CCHW)

Delta, Kelowna, BC –October 17, 2019 ( Newswire), a global news source covering leading sectors including marijuana and hemp stocks and its potcast site,  release today’s edition of potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

Good afternoon and welcome to another episode of "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts

In today’s podcast we look today’s early announcements.

Aurora Cannabis Inc. (NYSE: ACB(TSX: ACB) announced its plans for the roll-out of vapes, concentrates, and edibles when they are permitted for sale to consumers in December. The Company has prioritized its resources to prepare for a successful initial launch that will support an ongoing replenishment strategy to help ensure consumers across Canada will have access to a diverse portfolio of high-quality derivative products they want to buy.

You can watch a compilation of our commercial production of vapes, mints, chocolates and gummies HERE.
Photos are available on Aurora's Investor website HERE.

"Aurora's Product Development and Insights teams have done tremendous work to formulate new products in a variety of formats that we think will exceed consumer expectations and drive category growth," said Aurora CEO Terry Booth. "Aurora has built industry-leading cannabis capacity and scalability supported by our consumer research and retail distribution bench strength to launch this next generation of cannabis products into the Canadian market. We are ready to ship product as soon as the regulations allow and are excited for consumers and patients to finally have access to a greater selection of product forms. We are already working on expanding the range of new products beyond those that will initially launch."

To support the successful launch of vapes, concentrates, and edibles products, and to continue to ensure sufficient supply for domestic and international markets, Aurora has established production hubs in Eastern and Western Canada at Aurora River (Bradford, Ontario), Aurora Vie (Pointe Claire, Quebec) and at Aurora Sky (Leduc, Alberta).
These centres are intended to provide centralized production, packaging, logistics and distribution capabilities. In total, they comprise more than 450,000 square feet and are strategically located to efficiently distribute Aurora's products to markets across the country. In addition, Aurora Air, a 20,000 square foot manufacturing facility near Aurora Sky at the Edmonton International Airport, will be home to several of the new production lines for edible products. Aurora's next generation products have been formulated to meet or exceed all regulatory requirements. All new cannabis product forms are subject to a legislated Health Canada 60-day review period that begins on October 17, 2019.

Geyser Brands Inc. (formerly Kanzen Capital Corp.) (TSX-V: GYSRannounced that its subsidiary, 0957102 B.C. Ltd. DBA Apothecary Botanicals, is preparing to commence its co-packing and manufacturing operations as a means to grow Geyser Brands' in-house brands, as well as bolster its operations by partnering with third-party consumer-packaged goods brands, to bring cannabis to the mainstream in the health and wellness sector.

Apothecary Botanicals has signed a non-binding letter of intent to enter into a co-packing agreement between Geyser Brands' subsidiary, Apothecary Botanicals, and The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF), for the production and launch of Yield Growth's Canadian cannabis brand 'Jack n Jane', a line of cannabis-infused products including tinctures, topicals, and capsules.

Apothecary Botanicals has been engaged to manufacture and distribute Yield Growth's 'Jack n Jane' products, combining Yield Growth's proprietary formulations with Apothecary Botanical's cannabis supply, services, facilities, equipment, and required Health Canada licenses for processing and sales. Yield Growth will supply all non-cannabis ingredients, packaging, and design while Apothecary Botanicals will supply cannabis containing THC and/or CBD as required for the various product formulations. The first phase of production is expected to include three tinctures containing THC and CBD, with a goal of coming to market by December 31, 2019.

Apothecary Botanicals CEO, David Eto, commented, "I'm very pleased that Apothecary Botanicals can leverage its manufacturing, formulation, and distribution capabilities to assist Yield Growth expand into the Canadian market. Our in-house expertise in the food & beverage sector will add tremendous value to cannabis brands entering the Edibles market worth an estimated C$2.7 billion annually in Canada alone. Our facilities are GMP-compliant and managed by food sector specialists who understand the importance of food safety and quality. Our business principles are grounded in building a transparent, cost effective, and trusting partnership that will create long lasting business relationships and positive experiences for customers who will consume edibles."

Geyser Brands CEO, Andreas Thatcher, commented, "The goal of Apothecary Botanicals is to deliver innovative formulations and high-quality manufacturing using cannabis as an ingredient. This LOI shows that we are delivering on both. As the new cannabis legislation comes into force, we are scaling our licensed production into beverages, edibles and cosmetics. Our experience in food and beverage, cosmetics, and GMP manufacturing provides a complete platform for brands to enter the Canadian cannabis market."

48North Cannabis Corp. (TSXV:NRTHannounced that it has signed an exclusive licensing agreement with U.S.-based APCNA Holdings LLC. ("Apothecanna"), to bring its best-selling, premium cannabis topicals brand to Canadian consumers.

Apothecanna, an established U.S cannabis brand focused on organic topical formulations, made without the use of artificial ingredients, fillers, parabens, or GMO ingredients, has been a leading topicals brand in the United States since its founding in 2009. Apothecanna has developed a suite of next-generation health and wellness cannabis products including, but not limited to: pain relief creams, a skincare line, sex oils, and other therapeutic cannabis-based topicals.

48North is focused on delivering best-in-class and innovative next-generation cannabis products to Canadian consumers. To that end, the Company strongly believes that value-added cannabis products that have succeeded in mature U.S markets, will also succeed in the Canadian marketplace. The agreement with Apothecanna, on the heels of the Company's previously announced licensing agreements with Avitas and Mother & Clone, builds on 48North's growing portfolio of popular U.S-based cannabis brands.

"Without question, Apothecanna is one of the leading topical cannabis brands in the United States. Since 2009, Apothecanna has led the charge in combating cannabis stigma through spreading the wisdom of traditional plant medicine. They have successfully formulated a suite of best-in-class health and wellness products and developed an industry-leading brand. We are so excited to announce that Apothecanna's products will soon be available for Canadian consumers," said Alison Gordon, CEO of 48North.

"Great partnerships require shared values, and, like us, 48North is all about innovation and performance. Their commitment to sustainability and all-natural ingredients gave us the confidence we needed to expand our business into Canada. We look forward to combining our formulations and expertise with 48North's high-quality outdoor cannabis with the vision of normalizing cannabis through sport with the help of Good:Farm and 48North," said James Kennedy, Founder and CEO, of Apothecanna.

Under the terms of the licensing agreement signed October 16, 2019, 48North will license Apothecanna intellectual property and manufacturing techniques for domestic consumption in Canada.

Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPTannounced that it entered into an agreement to provide extraction services to a large U.S.-based farming services operation. Under the contract terms, Neptune will receive hemp biomass to be processed and transformed into crude oil extracts. The 2-year agreement could reach a total value in excess of US$20 million. The first shipment of biomass is expected to arrive at Neptune's North Carolina facility in the coming weeks.

"This large contract will support our capacity expansion at our North Carolina facility and better position us to serve the growing United States market. Our expansion in North Carolina is on time and on budget with extraction capacity expected to reach an annual run-rate of 1,500,000 kg of biomass by December 2019. Demand for extraction and formulation services in the U.S. is currently strong with the ongoing harvest season and our tolling and formulation pipeline to deliver high quality full and broad spectrum extracts remains robust. This announcement represents a further step towards our customer and geographic diversification strategy," said Michael Cammarata, Neptune's CEO.

Neptune also recently appointed Brett DuBose as Vice-President of Sales for the U.S. Region. Brett has more than 20 years of sales experience, most recently with Lonza Consumer Health and Nutrition where he was Associate Director Sales, for the Eastern U.S and Canada. He has also worked for 14 years at Pfizer in the Capsugel division, his last role being a Sales Manager Generic & Dietary Supplement. "With his extensive industry contacts and experience, Brett will play a key role in helping Neptune accelerate its market penetration in the U.S.," said Mr. Cammarata.

Once Neptune's near-term capacity expansion plans are complete and the Canadian expansion approved by Health Canada, the Company is expected to have a total extraction capacity of 3,000,000 kg of biomass annually, spread equally between Canada and the U.S.

SOL Global Investments Corp. (CSE: SOL) (OTC: SOLCFannounced that 3 Boys Farms, LLC , which owns and operates one of the original fourteen (14) medical marijuana treatment center licenses in Florida, will now operate under the business name "One Plant" after receiving the required regulatory approvals. SOL Global embraced the name One Plant for 3 Boys Farm and the Company's proposed dispensaries nationwide as the team firmly believes that just this "one" plant can solve countless problems. Chief Executive Officer Brady Cobb said "this One Plant can provide relief to patients suffering from so many debilitating conditions and illnesses and can help patients avoid dangerously addictive opioids, and this One Plant can also enhance and enrich patient's lives by giving them the freedom to enjoy daily life in a meaningful way." The name change comes as SOL Global accelerates its transition to a cannabis multi-state operator.

Additionally, One Plant is proud to announce that its proprietary delivery model, which launched in early July 2019, has shown tremendously positive results. From the launch in early July through October 3, 2019, One Plant, known for its best in class cannabis flower which is organically grown, has seen continued week over week delivery growth of 20% or more, week over week patient onboarding of 20% or more, and over a 300% increase in call volumes and orders from patients in Florida. During the week of October 4-10, 20191, One Plant's sales accelerated once it harvested and cured its first harvest after the previously announced operational upgrades were implemented at its Ruskin, Florida greenhouse facility. This harvest, which included One Plant's Ebony & Ivory strain which test results confirmed had a market leading THC content of 27%, resulted in One Plant sales increasing 140% week over week as compared to the previous reporting period. One Plant rose to 7th (out of 14 MMTC's) in flower sales in Florida, and 10th in overall sales in Florida, respectively1. What is more impressive is that One Plant achieved this increased sales volume all via its proprietary home delivery system, and without having a single dispensing location open.

"The fact we outsold our competitors, several of whom have over a dozen brick and mortar locations, is a testament to the power of our home delivery model," said CEO Brady Cobb. "With less capital expenditure, One Plant's efficiently scaled operations cut right to the bottom line. We are excited about opening up new strategically located stores that will serve as both retail dispensaries and prime delivery hubs to boost sales and EBITDA growth."
By the end of October 2019, One Plant is expected to open its first two (2) retail stores in Boynton Beach and Jacksonville Beach, respectively, with four (4) more locations anticipated for 2019.

Having just obtained Good Agricultural Practices-Farm (GAP) and Good Manufacturing Processing (GMP) approvals for its state-of-the-art cannabis cultivation facility in Ruskin, Florida, One Plant is positioned to become one of the United States' leading cannabis farms and distribution centers.

Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) one of the largest fully integrated operators in the global medical cannabis industry with licenses across the US and EU, announced the addition of four new dispensaries with openings in Maryland, Delaware and Florida.

Columbia Care’s facility in Chevy Chase represents the Company’s first dispensary in Maryland, a state with more than 100,000 registered patients and a market projected to reach sales in excess of $200 million by year end 2019. The facility’s proximity to Washington, D.C., Delaware, Virginia and Pennsylvania, all markets where Columbia Care operates, allows it to serve as one of the cornerstones for the Company’s mid-Atlantic strategy.

Columbia Care also opened its second dispensary in Delaware, located in Wilmington. With approximately 9,000 patients expected to be registered in the state’s medical program in 2019, Delaware lawmakers are expected to introduce adult use legislation in 2020, which could significantly increase patient access as well as the size of the total addressable market.

Finally, the Company has added two more dispensaries in Florida with the opening of its Sarasota and Jacksonville facilities, bringing the total number of dispensaries open in the state to three. With over 375,000 registered patients, Florida remains one of the largest medical cannabis markets in the world.

“No debt and a significant cash position gives Columbia Care one of the strongest balance sheets in the industry with access to the growth capital required to fund our 2019 strategic plan to operationalize all of our existing licenses,” said Nicholas Vita, chief executive officer of Columbia Care. “We are proud to execute on the plan we previously described to our investors, and by leveraging this strong foundation, we look forward to reaping the benefits of having one of the largest organically developed national cannabis platforms in the US. Opening these four additional dispensaries in key markets across the country represents significant progress and points to an accelerated pace of activity as we near the completion of this transformational year.”

The Company will offer the CNC Card, the nation’s first legal credit card for cannabis purchases, at each of these new locations. In addition, subject to regulatory approval, the company also intends to offer its proprietary home delivery service, “CC@Home,” which, together with the CNC Card, is designed to provide a convenient and comfortable guest experience as well as improved access to high-quality cannabis products capable of addressing a range of unmet health and wellness needs.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   

Subscribe to the new cannabis podcast series:

To hear more podcasts visit: podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About - News that Inspires Big Investing Ideas is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: Learn more about publishing your news release and our other news services on the newswire and
Global investors must adhere to regulations of each country. Please read privacy policy:

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Follow us on Social Media



Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

No comments:

Post a Comment